Alnylam Pharmaceuticals and The Medicines Company Announce that New ALN-PCSsc Results from Late-Breaking Presentation at American Heart Association Meeting Confirm Potential for Bi-Annual Hypercholest

Go back to Alnylam Pharmaceuticals and The Medicines Company Announce that New ALN-PCSsc Results from Late-Breaking Presentation at American Heart Association Meeting Confirm Potential for Bi-Annual Hypercholest
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 266.11 --0 (-0%)
Previous Close $266.11    52 Week High $109.10 
Open $266.11    52 Week Low $31.38 
Day High $266.11    P/E N/A 
Day Low $266.11    EPS $-1.45 
Volume 1,852       

Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) Delayed: 18.73 --0 (-0%)
Previous Close $18.73    52 Week High $18.64 
Open $18.73    52 Week Low $12.59 
Day High $18.73    P/E N/A 
Day Low $18.73    EPS $0.00 
Volume 661       

Medicines Co (NASDAQ: MDCO) Delayed: 84.90 --0 (-0%)
Previous Close $84.90    52 Week High $43.00 
Open $3.15    52 Week Low $27.50 
Day High $84.90    P/E 339.60 
Day Low $84.90    EPS $0.25 
Volume 413,822